z-logo
Premium
Contribution of CYP3A5 genetic polymorphism in cyclosporine pharmacokinetics assessed from routine TDM data using mixed effect modeling
Author(s) -
Chung J.,
Cho J.,
Lim H.,
Hong K.,
Oh D.,
Yi S.,
Shin S.,
Jang I.
Publication year - 2003
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/s0009-9236(03)90565-0
Subject(s) - pharmacokinetics , pharmacology , medicine , clinical pharmacology , cyp3a5 , pharmacogenetics , polymorphism (computer science) , biology , genetics , genotype , gene
Clinical Pharmacology & Therapeutics (2003) 73 , P56–P56; doi:

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here